Latest placebo Stories
Results indicate Zalviso controlled moderate-to-severe acute pain following abdominal surgery better than placebo, with similar side effect profile REDWOOD CITY, Calif., Oct.
Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources RIDGEFIELD, Conn., Oct.
MIAMI and NEW YORK, Oct.
--Study Demonstrated Clinically Meaningful and Statistically Significant Improvement of Agitation in Patients with Alzheimer's Disease-- ALISO VIEJO, Calif., Oct.
WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 10, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.
Research conducted on slaughterhouse workers with chronic pain symptoms. AKRON, Ohio, Oct.
-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications.
FLORHAM PARK, N.J., Oct.
CORAL SPRINGS, Florida, September 19, 2014 /PRNewswire/ -- BioTech News Coverage: Progress made as biotech companies release latest developments, patents and results of
- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc.